Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “glucocorticoid”

112 pharma patents match "glucocorticoid" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 112
Index total 30,257
Page 4 / 5

Quick answer

This filtered view shows 112 pharmaceutical patents matching "glucocorticoid" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

112 results for “glucocorticoid” · 30,257 patents in full index Clear search

  1. US 10314850

    Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  2. US 10272074

    Inhibitors of glucocorticoid receptor translocation

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  3. US 10238659

    Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  4. US 10231983

    Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  5. US 10213414

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  6. US 10195214

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  7. US 10117852

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  8. US 10047082

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  9. US 9980976

    Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists

    Northwestern University · Granted May 29, 2018 · Expires May 24, 2038

    granted

  10. US 9956216

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  11. US 9943505

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  12. US 9707223

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  13. US 9321736

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  14. US 9273047

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  15. US 9217026

    Method of inactivating a glucocorticoid receptor gene in an isolated cell

    Sangamo Biosciences, Inc. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  16. US 8940705

    Method of treating disease and selectively modulating transcriptional regulation by a glucocorticoid receptor by administering aclacinomycin and dexamethasone

    The Regents of the University of California · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  17. US 8921348

    Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  18. US 8906917

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  19. US 8859774

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  20. US 8829024

    Combination steroid and glucocorticoid receptor antagonist therapy

    Corcept Therapeutics Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  21. US 8741880

    Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

    Corcept Therapeutics Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  22. US 8685973

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  23. US 8598149

    Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  24. US 8557839

    Fused ring azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.